MT3 and prostate cancer: Androgen, cadmium, and arsenic enhanced gene expression of MT1/2 & MT3 in prostate carcinoma poorly metastatic prostate carcinoma cells (LNCaP).Significant increase in cell proliferation,invasion, and tumorigenic in highly invasive prostate cancer cells (PC-3) with overexpression of MT3